(S)-2-Nitro-N-(1-phenyl-2-pyrrolidin-1-yl-ethyl)-benzenesulfonamide, 98.0%, 1g

(3R)-3-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, 97%, 100mg

3-(2-Aminothiazol-4-yl)benzoic acid, 95.0%, 5g

Ethyl pentanoate, 95.0%, 25g

(S)-1-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)pyrrolidin-3-amine, 97%, 10mg

1-Tosyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-7-(tert-butoxy)-7-oxoheptanoic acid, 95+%, 1g

Piastre TLC SIL G-25, 5 x 10 cm, 50 Pezzo(i)

Methyl 2-((tert-butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoate, 95.0%, 5g

3-Azetidinol, 3-[2-(trifluoromethyl)phenyl]-, hydrochloride (1:1), 98%, 100mg

1,2,3,4,6,7,8,9-Octahydrophenazine, 97%, 500mg

2,3-Difluoro-6-methoxybenzonitrile, 95.0%, 5g

1-(4-Fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one, 95.0%, 250mg